SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-08-007276
Filing Date
2008-11-14
Accepted
2008-11-14 11:30:41
Documents
5
Period of Report
2008-09-30

Document Format Files

Seq Description Document Type Size
1 ALSERES PHARMACEUTICALS, INC. b72321ape10vq.htm 10-Q 395440
2 EX-31.1 SECTION 302 CERTIFICATION OF THE CEO b72321apexv31w1.htm EX-31.1 8037
3 EX-31.2 SECTION 302 CERTIFICATION OF THE CFO b72321apexv31w2.htm EX-31.2 8382
4 EX-32.1 SECTION 906 CERTIFICATION OF THE CEO b72321apexv32w1.htm EX-32.1 2969
5 EX-32.2 SECTION 906 CERTIFICATION OF THE CFO b72321apexv32w2.htm EX-32.2 2784
  Complete submission text file 0000950135-08-007276.txt   419324
Mailing Address 239 SOUTH STREET HOPKINTON MA 01748
Business Address 239 SOUTH STREET HOPKINTON MA 01748 508-497-2360
ALSERES PHARMACEUTICALS INC /DE (Filer) CIK: 0000094784 (see all company filings)

IRS No.: 870277826 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-06533 | Film No.: 081188178
SIC: 2834 Pharmaceutical Preparations